About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tg(DO11.10)10Dlo
transgene insertion 10, Dennis Y Loh
MGI:2664398
Summary 28 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Grb2tm1.1Hua/Grb2tm1.1Hua
Tg(DO11.10)10Dlo/0
Tg(Lck-cre)1Jtak/0
involves: 129 * BALB/c * C3H * C57BL/6 MGI:4818271
cn2
Gata3tm1Iho/Gata3tm1Iho
Tg(DO11.10)10Dlo/0
Tg(Lck-cre)1Cwi/0
involves: BALB/c * C3H * C57BL/6 MGI:4417857
cn3
Gata3tm1Iho/Gata3tm1Iho
Tg(Cd4-cre)1Cwi/0
Tg(DO11.10)10Dlo/0
involves: BALB/c * C3H * C57BL/6 * DBA/2 MGI:4417858
cx4
Il2tm1Hor/Il2tm1Hor
Tg(DO11.10)10Dlo/?
C.Cg-Il2tm1Hor Tg(DO11.10)10Dlo MGI:3759780
cx5
Stat2tm1Jdf/Stat2tm1Jdf
Tg(DO11.10)10Dlo/0
C.Cg-Stat2tm1Jdf Tg(DO11.10)10Dlo MGI:3529466
cx6
Slatm1Weis/Slatm1Weis
Tg(DO11.10)10Dlo/0
involves: 129 * BALB/c * C3H * C57BL/6 MGI:3033125
cx7
Tg(DO11.10)10Dlo/0
Crlf2tm1Wjl/Crlf2tm1Wjl
involves: 129 * BALB/c * C3H * C57BL/6 MGI:3624449
cx8
Prkcqtm1Litt/Prkcqtm1Litt
Tg(DO11.10)10Dlo/0
involves: 129 * BALB/c * C3H * C57BL/6 MGI:4843460
cx9
Cd28tm1Pjl/Cd28tm1Pjl
Tg(DO11.10)10Dlo/0
involves: 129P2/OlaHsd * BALB/c * C3H * C57BL/6 MGI:2664411
cx10
Git2Gt(XG510)Byg/Git2Gt(XG510)Byg
Tg(DO11.10)10Dlo/0
involves: 129P2/OlaHsd * BALB/c * C3H * C57BL/6 MGI:4461272
cx11
Il13tm1.1Anjm/Il13tm1.1Anjm
Tg(DO11.10)10Dlo/0
involves: 129P2/OlaHsd * BALB/c * C3H * C57BL/6 MGI:3850558
cx12
Ccr7tm1Rfor/Ccr7tm1Rfor
Tg(DO11.10)10Dlo/?
involves: 129P2/OlaHsd * BALB/c * C3H * C57BL/6 MGI:4430569
cx13
Nfatc3tm1Glm/Nfatc3tm1Glm
Tg(DO11.10)10Dlo/?
involves: 129S2/SvPas * BALB/c * C3H * C57BL/6 MGI:3525155
cx14
Zap70tm2.1Weis/Zap70tm2.1Weis
Tg(DO11.10)10Dlo/?
involves: 129S4/SvJae * BALB/c * C3H * C57BL/6 MGI:4399134
cx15
Ctla4tm1Shr/Ctla4tm1Shr
Tg(DO11.10)10Dlo/0
involves: 129S4/SvJae * BALB/c * C3H * C57BL/6 MGI:3714354
cx16
Itktm1Litt/Itktm1Litt
Tg(DO11.10)10Dlo/0
involves: 129S4/SvJae * BALB/c * C3H * C57BL/6J MGI:3771808
cx17
Ebi3Gt716Lex/Ebi3Gt716Lex
Tg(DO11.10)10Dlo/0
involves: 129S5/SvEvBrd * BALB/c * C3H * C57BL/6 MGI:3795472
cx18
Igh-Jtm1Mcdl/Igh-Jtm1Mcdl
Igk-Jtm1Mcdl/Igk-Jtm1Mcdl
Rag1tm1Mom/Rag1tm1Mom
Tg(DO11.10)10Dlo/?
involves: 129S/Sv * BALB/c * C3H * C57BL/6 MGI:3586594
cx19
Ctla4tm1Shr/Ctla4tm1Shr
Rag2tm1Fwa/Rag2tm1Fwa
Tg(DO11.10)10Dlo/0
involves: 129S/Sv * BALB/c * C3H * C57BL/6 MGI:3714326
cx20
Tg(DO11.10)10Dlo/?
Toxtm1.1Kay/Toxtm1.1Kay
involves: 129S/Sv * BALB/c * C3H * C57BL/6 MGI:3807780
cx21
Rag2tm1Fwa/Rag2tm1Fwa
Tg(DO11.10)10Dlo/0
involves: 129S/SvEv * BALB/c * C3H * C57BL/6 MGI:3714327
cx22
Btlatm1Kmm/Btlatm1Kmm
Tg(DO11.10)10Dlo/?
involves: 129S/SvEv * BALB/c * C3H * C57BL/6 MGI:3841449
cx23
Hivep2tm1Sis/Hivep2tm1Sis
Tg(DO11.10)10Dlo/?
involves: BALB/cA * C3H * C57BL/6NCrlj * CBA/JNCrlj MGI:3615666
cx24
Sh2d1atm1Pls/Sh2d1atm1Pls
Tg(DO11.10)10Dlo/Tg(DO11.10)10Dlo
involves: BALB/c * C3H * C57BL/6 MGI:3044989
cx25
Ksr1tm1Shaw/Ksr1tm1Shaw
Tg(DO11.10)10Dlo/0
involves: BALB/c * C3H * C57BL/6 MGI:3841456
cx26
Zap70m1Saka/Zap70m1Saka
Tg(DO11.10)10Dlo/0
involves: BALB/c * C3H * C57BL/6 MGI:3698742
cx27
Slamf1tm1Cpt/Slamf1tm1Cpt
Tg(DO11.10)10Dlo/Tg(DO11.10)10Dlo
involves: BALB/c * C3H * C57BL/6 MGI:3044988
tg28
Tg(DO11.10)10Dlo/? involves: BALB/c * C3H * C57BL/6 MGI:3606694


Genotype
MGI:4818271
cn1
Allelic
Composition
Grb2tm1.1Hua/Grb2tm1.1Hua
Tg(DO11.10)10Dlo/0
Tg(Lck-cre)1Jtak/0
Genetic
Background
involves: 129 * BALB/c * C3H * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Grb2tm1.1Hua mutation (0 available); any Grb2 mutation (43 available)
Tg(DO11.10)10Dlo mutation (7 available)
Tg(Lck-cre)1Jtak mutation (3 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• positive selection of CD4+ cells is severely impaired compared to in DO11.10 TCR control mice

hematopoietic system
• positive selection of CD4+ cells is severely impaired compared to in DO11.10 TCR control mice




Genotype
MGI:4417857
cn2
Allelic
Composition
Gata3tm1Iho/Gata3tm1Iho
Tg(DO11.10)10Dlo/0
Tg(Lck-cre)1Cwi/0
Genetic
Background
involves: BALB/c * C3H * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gata3tm1Iho mutation (0 available); any Gata3 mutation (32 available)
Tg(DO11.10)10Dlo mutation (7 available)
Tg(Lck-cre)1Cwi mutation (3 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
• partial impairment in generation of double positive cells
• partial arrest at the double negative 3 (DN3) to double negative 4 (DN4) transition

immune system
• partial impairment in generation of double positive cells
• partial arrest at the double negative 3 (DN3) to double negative 4 (DN4) transition

endocrine/exocrine glands




Genotype
MGI:4417858
cn3
Allelic
Composition
Gata3tm1Iho/Gata3tm1Iho
Tg(Cd4-cre)1Cwi/0
Tg(DO11.10)10Dlo/0
Genetic
Background
involves: BALB/c * C3H * C57BL/6 * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gata3tm1Iho mutation (0 available); any Gata3 mutation (32 available)
Tg(Cd4-cre)1Cwi mutation (10 available)
Tg(DO11.10)10Dlo mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
• severe reduction in single positive (SP) CD4 cells and no enrichment of SP CD8 cells

immune system
• severe reduction in single positive (SP) CD4 cells and no enrichment of SP CD8 cells




Genotype
MGI:3759780
cx4
Allelic
Composition
Il2tm1Hor/Il2tm1Hor
Tg(DO11.10)10Dlo/?
Genetic
Background
C.Cg-Il2tm1Hor Tg(DO11.10)10Dlo
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il2tm1Hor mutation (5 available); any Il2 mutation (43 available)
Tg(DO11.10)10Dlo mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• the mean survival time is 4 months, which is significantly shorter than the average life expectancy of BALB/C mic
• however, the mean survival time is much longer than Il2 null mice on a BALB/c background that do not carry the TCR transgene

immune system
• when transferred into athymic mice, CD4 T cells continue to proliferate for up to three weeks in response to antigen
• CD 4 T cells from these transfer experiments also express high levels of activation markers
• However, when transferred with wild-type CD4-postive CD25-positive T cells, the mutant CD4 T cells stop proliferating between one to two weeks after antigen encounter
• when transferred into athymic mice, there are 10-100 fold higher numbers of activated T cells three weeks after antigen
• the abnormal proliferation of CD4 T cells upon transfer into athymic mice is reduced by the addition of wild-type CD4-postive CD25-positive T cells
• this suggests there is a defect in the regulatory T cell population in these mice

hematopoietic system
• when transferred into athymic mice, CD4 T cells continue to proliferate for up to three weeks in response to antigen
• CD 4 T cells from these transfer experiments also express high levels of activation markers
• However, when transferred with wild-type CD4-postive CD25-positive T cells, the mutant CD4 T cells stop proliferating between one to two weeks after antigen encounter
• when transferred into athymic mice, there are 10-100 fold higher numbers of activated T cells three weeks after antigen
• the abnormal proliferation of CD4 T cells upon transfer into athymic mice is reduced by the addition of wild-type CD4-postive CD25-positive T cells
• this suggests there is a defect in the regulatory T cell population in these mice

cellular
• when transferred into athymic mice, CD4 T cells continue to proliferate for up to three weeks in response to antigen
• CD 4 T cells from these transfer experiments also express high levels of activation markers
• However, when transferred with wild-type CD4-postive CD25-positive T cells, the mutant CD4 T cells stop proliferating between one to two weeks after antigen encounter




Genotype
MGI:3529466
cx5
Allelic
Composition
Stat2tm1Jdf/Stat2tm1Jdf
Tg(DO11.10)10Dlo/0
Genetic
Background
C.Cg-Stat2tm1Jdf Tg(DO11.10)10Dlo
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Stat2tm1Jdf mutation (0 available); any Stat2 mutation (39 available)
Tg(DO11.10)10Dlo mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
N
• IFN-alpha stimulation does not promote Th1 cell development similar to Stat2 wild-type mice and unlike in humans




Genotype
MGI:3033125
cx6
Allelic
Composition
Slatm1Weis/Slatm1Weis
Tg(DO11.10)10Dlo/0
Genetic
Background
involves: 129 * BALB/c * C3H * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Slatm1Weis mutation (1 available); any Sla mutation (21 available)
Tg(DO11.10)10Dlo mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
• enhanced positive selection, resulting in an increase in the number of cells that mature to the single positive stage relative to wild-type

immune system
• enhanced positive selection, resulting in an increase in the number of cells that mature to the single positive stage relative to wild-type




Genotype
MGI:3624449
cx7
Allelic
Composition
Tg(DO11.10)10Dlo/0
Crlf2tm1Wjl/Crlf2tm1Wjl
Genetic
Background
involves: 129 * BALB/c * C3H * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Crlf2tm1Wjl mutation (1 available); any Crlf2 mutation (21 available)
Tg(DO11.10)10Dlo mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• when transgenic mutant mice are injected with OVA, there is little induction of CD69+ on CD4+ T cells; CD69+ expression is significantly induced on CD 4+ cells of nontransgenic Tpte2-deficient controls




Genotype
MGI:4843460
cx8
Allelic
Composition
Prkcqtm1Litt/Prkcqtm1Litt
Tg(DO11.10)10Dlo/0
Genetic
Background
involves: 129 * BALB/c * C3H * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Prkcqtm1Litt mutation (3 available); any Prkcq mutation (51 available)
Tg(DO11.10)10Dlo mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• induced by Fas

cellular
• induced by Fas

hematopoietic system
• induced by Fas




Genotype
MGI:2664411
cx9
Allelic
Composition
Cd28tm1Pjl/Cd28tm1Pjl
Tg(DO11.10)10Dlo/0
Genetic
Background
involves: 129P2/OlaHsd * BALB/c * C3H * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd28tm1Pjl mutation (0 available); any Cd28 mutation (52 available)
Tg(DO11.10)10Dlo mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• naive T cells are able to initiate a response to antigen but show decreased sensitivity to lower antigen concentrations and are unable to maintain their proliferative response
• naive CD4+ antigen-specific T cell responses to mitogen (Con A) activation are reduced in splenocytes
• thymocyte proliferative responses to OVA antigen are reduced
• 10- to 20-fold decrease in T cell IL-2 production when stimulated with OVA antigen

hematopoietic system
• naive T cells are able to initiate a response to antigen but show decreased sensitivity to lower antigen concentrations and are unable to maintain their proliferative response
• naive CD4+ antigen-specific T cell responses to mitogen (Con A) activation are reduced in splenocytes
• thymocyte proliferative responses to OVA antigen are reduced

endocrine/exocrine glands
• thymocyte proliferative responses to OVA antigen are reduced

cellular
• naive T cells are able to initiate a response to antigen but show decreased sensitivity to lower antigen concentrations and are unable to maintain their proliferative response
• naive CD4+ antigen-specific T cell responses to mitogen (Con A) activation are reduced in splenocytes




Genotype
MGI:4461272
cx10
Allelic
Composition
Git2Gt(XG510)Byg/Git2Gt(XG510)Byg
Tg(DO11.10)10Dlo/0
Genetic
Background
involves: 129P2/OlaHsd * BALB/c * C3H * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Git2Gt(XG510)Byg mutation (3 available); any Git2 mutation (78 available)
Tg(DO11.10)10Dlo mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
• single positive cell number in thymus
• transgene positive CD4 cells in spleen, lymph node and blood

immune system
• single positive cell number in thymus
• transgene positive CD4 cells in spleen, lymph node and blood




Genotype
MGI:3850558
cx11
Allelic
Composition
Il13tm1.1Anjm/Il13tm1.1Anjm
Tg(DO11.10)10Dlo/0
Genetic
Background
involves: 129P2/OlaHsd * BALB/c * C3H * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il13tm1.1Anjm mutation (0 available); any Il13 mutation (30 available)
Tg(DO11.10)10Dlo mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• Th2 T cells from these mice fail to induce airway hyperresponsive when transferred to immunodeficient hosts
• lymphocytes fail to produce IL-13

hematopoietic system
• Th2 T cells from these mice fail to induce airway hyperresponsive when transferred to immunodeficient hosts




Genotype
MGI:4430569
cx12
Allelic
Composition
Ccr7tm1Rfor/Ccr7tm1Rfor
Tg(DO11.10)10Dlo/?
Genetic
Background
involves: 129P2/OlaHsd * BALB/c * C3H * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ccr7tm1Rfor mutation (1 available); any Ccr7 mutation (29 available)
Tg(DO11.10)10Dlo mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• significantly reduced ability of T regulatory cells to enter mesenteric and peripheral lymph nodes
• more moderately reduced ability of T regulatory cells to enter Peyer's patches and the gut
• greater ability to migrate into the liver
• failure of T regulatory cells to localize to T cell zones of lymph nodes
• reduced movement of T regulatory cells away from peripheral sites of inflammation

cellular

hematopoietic system
• significantly reduced ability of T regulatory cells to enter mesenteric and peripheral lymph nodes
• more moderately reduced ability of T regulatory cells to enter Peyer's patches and the gut
• greater ability to migrate into the liver
• failure of T regulatory cells to localize to T cell zones of lymph nodes
• reduced movement of T regulatory cells away from peripheral sites of inflammation




Genotype
MGI:3525155
cx13
Allelic
Composition
Nfatc3tm1Glm/Nfatc3tm1Glm
Tg(DO11.10)10Dlo/?
Genetic
Background
involves: 129S2/SvPas * BALB/c * C3H * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Nfatc3tm1Glm mutation (1 available); any Nfatc3 mutation (71 available)
Tg(DO11.10)10Dlo mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
• size reduced 3 fold
• increased apoptosis of double positive cells

immune system
• size reduced 3 fold
• increased apoptosis of double positive cells

endocrine/exocrine glands
• size reduced 3 fold




Genotype
MGI:4399134
cx14
Allelic
Composition
Zap70tm2.1Weis/Zap70tm2.1Weis
Tg(DO11.10)10Dlo/?
Genetic
Background
involves: 129S4/SvJae * BALB/c * C3H * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(DO11.10)10Dlo mutation (7 available)
Zap70tm2.1Weis mutation (1 available); any Zap70 mutation (55 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
• a marked reduction in the proportion and absolute numbers of CD4 SP thymocytes, and lower percentages and lower absolute numbers of CD4+ T cells expressing the transgene in the spleens and lymph nodes

immune system
• a marked reduction in the proportion and absolute numbers of CD4 SP thymocytes, and lower percentages and lower absolute numbers of CD4+ T cells expressing the transgene in the spleens and lymph nodes




Genotype
MGI:3714354
cx15
Allelic
Composition
Ctla4tm1Shr/Ctla4tm1Shr
Tg(DO11.10)10Dlo/0
Genetic
Background
involves: 129S4/SvJae * BALB/c * C3H * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ctla4tm1Shr mutation (4 available); any Ctla4 mutation (54 available)
Tg(DO11.10)10Dlo mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
• mild splenomegaly observed in 6-8 week-old mice
• 3 to 4 days after priming with ovalbumin peptide and antigen-presenting cells, T cells produce Il-4, whereas Ctla4-sufficient, Tg(DO11.10)10Dlo cells do not
• T cells produce Th2 cytokines (Il-4, Il-5, and Il-10) upon restimulation with antigen and APCs, whereas Tg(DO11.10)10Dlo cells produce the Th1 cytokine interferon gamma; Th2 bias is seen over a range of peptide concentration during primary stimulation
• in recall responses, T cells proliferate more than wild-type Tg(DO11.10)10Dlo cells

immune system
• mild splenomegaly observed in 6-8 week-old mice
• 3 to 4 days after priming with ovalbumin peptide and antigen-presenting cells, T cells produce Il-4, whereas Ctla4-sufficient, Tg(DO11.10)10Dlo cells do not
• T cells produce Th2 cytokines (Il-4, Il-5, and Il-10) upon restimulation with antigen and APCs, whereas Tg(DO11.10)10Dlo cells produce the Th1 cytokine interferon gamma; Th2 bias is seen over a range of peptide concentration during primary stimulation
• in recall responses, T cells proliferate more than wild-type Tg(DO11.10)10Dlo cells
• mild lymphadenopathy observed in 6-8 week-old mice

growth/size/body
• mild splenomegaly observed in 6-8 week-old mice

cellular
• in recall responses, T cells proliferate more than wild-type Tg(DO11.10)10Dlo cells




Genotype
MGI:3771808
cx16
Allelic
Composition
Itktm1Litt/Itktm1Litt
Tg(DO11.10)10Dlo/0
Genetic
Background
involves: 129S4/SvJae * BALB/c * C3H * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Itktm1Litt mutation (2 available); any Itk mutation (50 available)
Tg(DO11.10)10Dlo mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• isolated T cells primed under Th2 conditions for 5 days, restimulated for 5 more days, then restimulated in absence of exogenous cytokine fail to produce Il4, although cell expansion is similar to wild-type; PMA/ionomycin restimulation of Th2-primed cells restores Il4 secretion

hematopoietic system
• isolated T cells primed under Th2 conditions for 5 days, restimulated for 5 more days, then restimulated in absence of exogenous cytokine fail to produce Il4, although cell expansion is similar to wild-type; PMA/ionomycin restimulation of Th2-primed cells restores Il4 secretion




Genotype
MGI:3795472
cx17
Allelic
Composition
Ebi3Gt716Lex/Ebi3Gt716Lex
Tg(DO11.10)10Dlo/0
Genetic
Background
involves: 129S5/SvEvBrd * BALB/c * C3H * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ebi3Gt716Lex mutation (0 available); any Ebi3 mutation (12 available)
Tg(DO11.10)10Dlo mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• following anti-CD3 antibody stimulation, differentiation into Th17 cells is increased compared to in wild-type mice
• following ovalbumin stimulation or infection with Listeriosis monocytogenes, Il-22 plasma levels are increased compared to in wild-type mice
• following ovalbumin stimulation or infection with Listeriosis monocytogenes
• following anti-CD3 antibody stimulation
• mice are resistant to infection with Listeriosis monocytogenes with a 45-fold less bacteria load in the spleen and a 150-fold less bacterial load in the liver after re-challenge compared to in similarly treated wild-type mice

homeostasis/metabolism
• following ovalbumin stimulation or infection with Listeriosis monocytogenes, Il-22 plasma levels are increased compared to in wild-type mice
• following ovalbumin stimulation or infection with Listeriosis monocytogenes

hematopoietic system
• following anti-CD3 antibody stimulation, differentiation into Th17 cells is increased compared to in wild-type mice




Genotype
MGI:3586594
cx18
Allelic
Composition
Igh-Jtm1Mcdl/Igh-Jtm1Mcdl
Igk-Jtm1Mcdl/Igk-Jtm1Mcdl
Rag1tm1Mom/Rag1tm1Mom
Tg(DO11.10)10Dlo/?
Genetic
Background
involves: 129S/Sv * BALB/c * C3H * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Igh-Jtm1Mcdl mutation (0 available); any Igh-J mutation (13 available)
Igk-Jtm1Mcdl mutation (0 available); any Igk-J mutation (11 available)
Rag1tm1Mom mutation (49 available); any Rag1 mutation (123 available)
Tg(DO11.10)10Dlo mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• the development of IL-4+IFNG- and IFNG+IL-4- T cells after immunization are increased but not if wild-type splenocytes are transferred into mutant mice
• germinal center formation is increased in mutants but not if wild-type splenocytes are transferred into mutant mice
• following immunization with a cross-linked OVA-HA antigen IgE levels are elevated by 2 orders of magnitude compared to mutant mice wild-type for Rag1; however serum Ig half-lives are normal
• following immunization with a cross-linked OVA-HA antigen IgG titers are increased compared to mutant mice wild-type for Rag1, with IgG1 titers increased about 20-fold

hematopoietic system
• the development of IL-4+IFNG- and IFNG+IL-4- T cells after immunization are increased but not if wild-type splenocytes are transferred into mutant mice
• germinal center formation is increased in mutants but not if wild-type splenocytes are transferred into mutant mice
• following immunization with a cross-linked OVA-HA antigen IgE levels are elevated by 2 orders of magnitude compared to mutant mice wild-type for Rag1; however serum Ig half-lives are normal
• following immunization with a cross-linked OVA-HA antigen IgG titers are increased compared to mutant mice wild-type for Rag1, with IgG1 titers increased about 20-fold

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
hyper IgE recurrent infection syndrome 1 DOID:3261 OMIM:147060
J:100072




Genotype
MGI:3714326
cx19
Allelic
Composition
Ctla4tm1Shr/Ctla4tm1Shr
Rag2tm1Fwa/Rag2tm1Fwa
Tg(DO11.10)10Dlo/0
Genetic
Background
involves: 129S/Sv * BALB/c * C3H * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ctla4tm1Shr mutation (4 available); any Ctla4 mutation (54 available)
Rag2tm1Fwa mutation (45 available); any Rag2 mutation (119 available)
Tg(DO11.10)10Dlo mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
N
• mice show no signs of T cell activation, lymphadenopathy, or splenomegaly over 32 weeks; T cells are naive, with no expression of activation markers
• primary response to antigen stimulation in vitro is similar to Rag1-null, Tg(DO11.10)10Dlo T cells
• during secondary response to low-dose antigen stimulation in vitro, T cells show 2.2-3 fold higher proliferation compared to Rag2-null, Tg(Do11.10)10Dlo mice
• transferred T cells are resistant to tolerance induction in vivo in hosts after a tolerizing dose of ovalbumin peptide; in vivo expansion of T cells 4 and 7 days after treatment is 2.2- and 1.4-fold greater than Rag2-null, transgenic mice
• T cells given a tolerogenic stimulus proliferate and secrete Il-2 robustly upon restimulation in contrast to poor response in Rag2-null, Tg(DO11.10)10Dlo mice
• T cells given a tolerogenic stimulus do not exhibit a blockade after entering G1 phase of cell cycle, and readily enter S phase, while Ctla4-sufficient mutant cells do not progress past G1
• during secondary response, on days 2 and 3, T cells show increased production of interferon gamma and Il-4 than transgenic, Rag2-null mice

hematopoietic system
• during secondary response to low-dose antigen stimulation in vitro, T cells show 2.2-3 fold higher proliferation compared to Rag2-null, Tg(Do11.10)10Dlo mice
• transferred T cells are resistant to tolerance induction in vivo in hosts after a tolerizing dose of ovalbumin peptide; in vivo expansion of T cells 4 and 7 days after treatment is 2.2- and 1.4-fold greater than Rag2-null, transgenic mice
• T cells given a tolerogenic stimulus proliferate and secrete Il-2 robustly upon restimulation in contrast to poor response in Rag2-null, Tg(DO11.10)10Dlo mice
• T cells given a tolerogenic stimulus do not exhibit a blockade after entering G1 phase of cell cycle, and readily enter S phase, while Ctla4-sufficient mutant cells do not progress past G1




Genotype
MGI:3807780
cx20
Allelic
Composition
Tg(DO11.10)10Dlo/?
Toxtm1.1Kay/Toxtm1.1Kay
Genetic
Background
involves: 129S/Sv * BALB/c * C3H * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(DO11.10)10Dlo mutation (7 available)
Toxtm1.1Kay mutation (0 available); any Tox mutation (39 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• transgenic T cell development is arrested after positive selection but before CD4+T cell lineage commitment
• mice exhibit severe lymphopenia with only a minor population of CD8+ T cells found in the spleen

hematopoietic system
• transgenic T cell development is arrested after positive selection but before CD4+T cell lineage commitment
• mice exhibit severe lymphopenia with only a minor population of CD8+ T cells found in the spleen




Genotype
MGI:3714327
cx21
Allelic
Composition
Rag2tm1Fwa/Rag2tm1Fwa
Tg(DO11.10)10Dlo/0
Genetic
Background
involves: 129S/SvEv * BALB/c * C3H * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rag2tm1Fwa mutation (45 available); any Rag2 mutation (119 available)
Tg(DO11.10)10Dlo mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
N
• T cells exhibit similar levels of activation induced cell death as Rag2-, Ctla4-deficient, Tg (DO11.10)10Dlo T cells
• cells undergo tolerance induction in vivo in response to an immunizing or tolerizing stimulus




Genotype
MGI:3841449
cx22
Allelic
Composition
Btlatm1Kmm/Btlatm1Kmm
Tg(DO11.10)10Dlo/?
Genetic
Background
involves: 129S/SvEv * BALB/c * C3H * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Btlatm1Kmm mutation (3 available); any Btla mutation (30 available)
Tg(DO11.10)10Dlo mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
• fully polarized TH1 cells show a 2-fold increase in proliferation in response to OVA peptide presented by either CD8+ or CD8-CD11c+ DCs

immune system
• fully polarized TH1 cells show a 2-fold increase in proliferation in response to OVA peptide presented by either CD8+ or CD8-CD11c+ DCs

cellular
• fully polarized TH1 cells show a 2-fold increase in proliferation in response to OVA peptide presented by either CD8+ or CD8-CD11c+ DCs




Genotype
MGI:3615666
cx23
Allelic
Composition
Hivep2tm1Sis/Hivep2tm1Sis
Tg(DO11.10)10Dlo/?
Genetic
Background
involves: BALB/cA * C3H * C57BL/6NCrlj * CBA/JNCrlj
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Hivep2tm1Sis mutation (2 available); any Hivep2 mutation (109 available)
Tg(DO11.10)10Dlo mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• impaired positive selection
• marked reduction in CD4+ single positive t cells after ovalbumin administration relative to controls
• both CD4+ and CD8+ single positive splenocytes reduced after ovalbumin administration
• enhanced generation of TH2 cells
• TH1 differentiation unaffected

hematopoietic system
• impaired positive selection
• marked reduction in CD4+ single positive t cells after ovalbumin administration relative to controls
• both CD4+ and CD8+ single positive splenocytes reduced after ovalbumin administration
• enhanced generation of TH2 cells
• TH1 differentiation unaffected




Genotype
MGI:3044989
cx24
Allelic
Composition
Sh2d1atm1Pls/Sh2d1atm1Pls
Tg(DO11.10)10Dlo/Tg(DO11.10)10Dlo
Genetic
Background
involves: BALB/c * C3H * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Sh2d1atm1Pls mutation (4 available); any Sh2d1a mutation (11 available)
Tg(DO11.10)10Dlo mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• CD4+ T cells produce less IL-4 following treatment with OVA peptide-pulsed antigen presenting cells




Genotype
MGI:3841456
cx25
Allelic
Composition
Ksr1tm1Shaw/Ksr1tm1Shaw
Tg(DO11.10)10Dlo/0
Genetic
Background
involves: BALB/c * C3H * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ksr1tm1Shaw mutation (0 available); any Ksr1 mutation (50 available)
Tg(DO11.10)10Dlo mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• decreased T cell proliferation when stimulated with ovalbumin peptide
• cultured T cells under conditions that promote either Th1 or Th2 differentiation fail to produce appreciable amounts of IFNG or IL4
• addition of supplemental IL2 allows for normal Th1 and Th2 differentiation
• at 24, 48, and 72 h after stimulation compared to controls

hematopoietic system
• decreased T cell proliferation when stimulated with ovalbumin peptide
• cultured T cells under conditions that promote either Th1 or Th2 differentiation fail to produce appreciable amounts of IFNG or IL4
• addition of supplemental IL2 allows for normal Th1 and Th2 differentiation

cellular
• decreased T cell proliferation when stimulated with ovalbumin peptide




Genotype
MGI:3698742
cx26
Allelic
Composition
Zap70m1Saka/Zap70m1Saka
Tg(DO11.10)10Dlo/0
Genetic
Background
involves: BALB/c * C3H * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(DO11.10)10Dlo mutation (7 available)
Zap70m1Saka mutation (1 available); any Zap70 mutation (55 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• T cells require a 10-fold greater concentration of ovalbumin peptide to proliferate to the same extent and wild-type Tg(DO11.10)10Dlo T cells
• number of CD4+CD8- mature thymocytes decreases to ~20% that in control Tg(DO11.10)10Dlo mice

hematopoietic system
• T cells require a 10-fold greater concentration of ovalbumin peptide to proliferate to the same extent and wild-type Tg(DO11.10)10Dlo T cells
• number of CD4+CD8- mature thymocytes decreases to ~20% that in control Tg(DO11.10)10Dlo mice

cellular
• T cells require a 10-fold greater concentration of ovalbumin peptide to proliferate to the same extent and wild-type Tg(DO11.10)10Dlo T cells




Genotype
MGI:3044988
cx27
Allelic
Composition
Slamf1tm1Cpt/Slamf1tm1Cpt
Tg(DO11.10)10Dlo/Tg(DO11.10)10Dlo
Genetic
Background
involves: BALB/c * C3H * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Slamf1tm1Cpt mutation (0 available); any Slamf1 mutation (24 available)
Tg(DO11.10)10Dlo mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• CD4+ T cells produce less IL-4 following treatment with OVA peptide-pulsed antigen presenting cells




Genotype
MGI:3606694
tg28
Allelic
Composition
Tg(DO11.10)10Dlo/?
Genetic
Background
involves: BALB/c * C3H * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(DO11.10)10Dlo mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• 20 hours after administration of OVA323-339 peptide, apoptosis, DNA degradation, chromatin condensation, and cell shrinkage occur in the majority of cortical thymocytes
• apoptosis occurs throughout the thymus including the subcapsular and deep cortical areas
• 3 days after administration of peptide the cortical thymus is acellular; however, normal cellularity exists in the medulla
• peptide administration does not effect small number of thymocytes that express only the beta chain transgene Vb8
• CD4+CD8+TCR cells in thymic cortex are reduced by 55% after administration of OVA 323-339 peptide
• CD4+ CD8- TCR thymocytes are reduced in absolute numbers after administration of OVA 323-339 peptide

hematopoietic system
• 20 hours after administration of OVA323-339 peptide, apoptosis, DNA degradation, chromatin condensation, and cell shrinkage occur in the majority of cortical thymocytes
• apoptosis occurs throughout the thymus including the subcapsular and deep cortical areas
• 3 days after administration of peptide the cortical thymus is acellular; however, normal cellularity exists in the medulla
• peptide administration does not effect small number of thymocytes that express only the beta chain transgene Vb8
• CD4+CD8+TCR cells in thymic cortex are reduced by 55% after administration of OVA 323-339 peptide
• CD4+ CD8- TCR thymocytes are reduced in absolute numbers after administration of OVA 323-339 peptide

endocrine/exocrine glands
• 20 hours after administration of OVA323-339 peptide, apoptosis, DNA degradation, chromatin condensation, and cell shrinkage occur in the majority of cortical thymocytes
• apoptosis occurs throughout the thymus including the subcapsular and deep cortical areas
• 3 days after administration of peptide the cortical thymus is acellular; however, normal cellularity exists in the medulla
• peptide administration does not effect small number of thymocytes that express only the beta chain transgene Vb8





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory